Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.51 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.51 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.51 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.51 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.51 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.51 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.51 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.51 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.51 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.51 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16893772 | 1.00 | ALDH1A1 (0.58) | ALDH1A1MAPK1HDAC1HDAC2HDAC3 | |
| SCHEMBL16893559 | 1.00 | ALDH1A1 (0.58) | ALDH1A1MAPK1HDAC1HDAC2HDAC3 | |
| SCHEMBL5145617 | 1.00 | ALDH1A1 (0.58) | ALDH1A1MAPK1HDAC1HDAC2HDAC3 | |
| SCHEMBL95941 | 1.00 | ALDH1A1 (0.58) | ALDH1A1MAPK1HDAC1HDAC2HDAC3 | |
| SCHEMBL5144121 | 1.00 | ALDH1A1 (0.58) | ALDH1A1MAPK1HDAC1HDAC2HDAC3 | |
| SCHEMBL16893942 | 1.00 | ALDH1A1 (0.58) | ALDH1A1MAPK1HDAC1HDAC2HDAC3 | |
| SCHEMBL97636 | 0.98 | ALDH1A1 (0.61) | ALDH1A1MAPK1HDAC1HDAC2HDAC3 | |
| SCHEMBL95488 | 0.91 | ALDH1A1 (0.64) | ALDH1A1MAPK1HDAC1HDAC2HDAC3 | |
| SCHEMBL5169003 | 0.89 | ALDH1A1 (0.74) | ALDH1A1MAPK1HDAC1HDAC2HDAC3 | |
| SCHEMBL5167895 | 0.89 | ALDH1A1 (0.74) | ALDH1A1MAPK1HDAC1HDAC2HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1697465-B1 | POLYMER NANOCOMPOSITES AND METHODS FOR THEIR PREPARATION | GEN ELECTRIC (US) | 2008-02-13 | — | — | EP | disclosed |
| EP-1697465-A2 | POLYMER NANOCOMPOSITES AND METHODS FOR THEIR PREPARATION | GENERAL ELECTRIC COMPANY (US) | 2006-09-06 | — | — | EP | disclosed |
| WO-2005061623-A2 | POLYMER NANOCOMPOSITES AND METHODS FOR THEIR PREPARATION | GENERAL ELECTRIC COMPANY (US) | 2005-07-07 | — | — | WO | disclosed |
| US-20050137310-A1 | Polymer nanocomposites and methods for their preparation | CITIBANK, N.A., AS COLLATERAL AGENT | 2005-06-23 | — | — | US | disclosed |
| US-5747560-A | AMMONIUM SALTS | ALLIEDSIGNAL INC. (US) | 1998-05-05 | — | — | US | disclosed |
| EP-0598836-B1 | MELT PROCESS FORMATION OF POLYMER NANOCOMPOSITE OF EXFOLIATED LAYERED MATERIAL | ALLIED SIGNAL INC (US) | 1997-10-15 | — | — | EP | disclosed |
| EP-0668888-A1 | NANOCOMPOSITES OF GAMMA PHASE POLYMERS | AlliedSignal Inc. (US) | 1995-08-30 | — | — | EP | disclosed |
| US-5385776-A | Polylactams | ALLIEDSIGNAL INC. | 1995-01-31 | — | — | US | disclosed |
| EP-0598836-A1 | MELT PROCESS FORMATION OF POLYMER NANOCOMPOSITE OF EXFOLIATED LAYERED MATERIAL. | ALLIED SIGNAL INC (US) | 1994-06-01 | — | — | EP | disclosed |
| WO-1994011430-A1 | NANOCOMPOSITES OF GAMMA PHASE POLYMERS | ALLIED-SIGNAL INC. (US) | 1994-05-26 | — | — | WO | disclosed |
| WO-1993004117-A1 | MELT PROCESS FORMATION OF POLYMER NANOCOMPOSITE OF EXFOLIATED LAYERED MATERIAL | ALLIED-SIGNAL INC. (US) | 1993-03-04 | — | — | WO | disclosed |
| WO-1993004118-A1 | MELT PROCESS FORMATION OF POLYMER NANOCOMPOSITE OF EXFOLIATED LAYERED MATERIAL | ALLIED-SIGNAL INC. (US) | 1993-03-04 | — | — | WO | disclosed |